Yuting (Jasmine) QiuEmail: ytqiu.jlu AT gmail DOT com
|
Dr. Qiu received the Ph.D degree in Chemical Engineering from Northeastern University. She worked with Prof. Su in the Su Nanomaterials and Nanomedicine Group. Before that she received her master degree in the Department of chemistry and chemical biology department, Northeastern University, USA, in Jan. 2015, Bachelor’s Degree in Engineering from School of Chemistry, Bachelor’s Degree in Actuarial Sciences from College of Mathematics, Jilin University, China, in Jul. 2013. From August. 2014, she was working with her Ph.D. advisor Prof. Su on Nanoparticle focused/enhanced X-ray radiation therapy , Precision medicines with 3D microtissue and Single cell array based DNA damage assay, and Multiplexed biomarker detection, Northeastern University, Boston, MA. Dr. Qiu also received Master of Public Health from Harvard School of Public Health in May 2018 and earned Master of Fine Arts from Berklee College of Music Dec. 2019. She has successfully finished several internships/coops in Harvard Medical School, pharmaceutical companies including Catabasis in Cambridge, MA and Bristol Myers Squibb, Cambridge, MA. She was a visiting student (Jan. 2010 ~ Jan. 2011) in School of Material Science and Engineering, Nanyang Technological University, Singapore. She worked as senior scientist in Crown Bioscience, taking multiple tasks like characterization and contamination detection of cell lines and organoids by barcode deep NGS sequencing, establishing tumour organoid biobank using Patient-Derived Xenograft (PDX) Library to enable drug discovery and translational research, creating matched in vivo/in vitro patient-derived model pairs of PDX and PDX-Derived organoids for cancer pharmacology research from May. 2020 to Aug. 2021.
|
![]() |
![]() |
![]() |
![]() |
![]() |